期刊文献+

多发性骨髓瘤合并肾功能不全患者的临床特点 被引量:1

Clinical Characteristics of Multiple Myeloma with Renal Insufficiency
下载PDF
导出
摘要 目的探讨多发性骨髓瘤合并肾功能不全患者的临床特点。方法随机抽取102例MM患者的临床资料,按照患者出现肾功能不全的时间不同分为A组、B组、C组。A组34例,B组12例,C组56例。A组患者在初诊时发现合并肾功能不全;B组患者为初诊时无肾功能不全者,在疾病进展过程中出现肾功能不全;C组为疾病治疗过程中未出现肾功能不全的患者。观察患者临床表现、免疫分型及临床疗效。结果 A组和B组患者Scr、血清钙、UA、β2-MG、浆细胞水平显著高于C组,差异有统计学意义(P<0.05)。A组LDH水平显著低于B组,差异有统计学意义(P<0.05)。46例合并肾功能不全的患者中,Ig Aλ轻链型的比例显著高于Ig Ak轻链型,差异有统计学意义(P<0.05)。C组中位生存期显著高于A组和B组,差异有统计学意义(P<0.05)。结论多发性骨髓瘤合并肾功能不全患者临床表现为高水平的Scr、血清钙、UA、β2-MG、浆细胞,而且Ig Aλ轻链型的比例较高。 Objective To explore the clinical characteristics of multiple myeloma combine with renal insufficiency.Methods 102 cases of patients with multiple myeloma were divided into group A( 34 cases),group B( 12 cases),and group C( 56 cases) according to the time of renal insufficiency. Renal insufficiency of group A were found at first diagnosis,renal insufficiency of group B appeared during progression,group C had no renal insufficiency. Clinical manifestation,immunophenotyping,and clinical effects were observed. Results The levels of Scr,blood calcium,UA,β2-MG,plasma cell of group A and group B were higher than those of group C( P〈0. 05). The levels of LDH of group A were lower than that of group B( P〈0. 05). Among 46 cases of patients with renal insufficiency,the ratio of Ig Aλ light chain type was higher than that of Ig Ak light chain type( P〈0. 05).The mean survival of group C was higher than that of group A and group B. Conclusion Clinical manifestation of multiple myeloma with renal insufficiency are high levels of Scr,blood calcium,UA,β2-MG,and plasma cell,and high ration of Ig Aλ.
出处 《实用癌症杂志》 2016年第5期836-838,共3页 The Practical Journal of Cancer
关键词 多发性骨髓瘤 肾功能不全 临床特点 Multiple myeloma Renal insufficiency Clinical characteristics
  • 相关文献

参考文献11

二级参考文献35

  • 1李征洋,侯健.骨髓瘤患者经白蛋白校正后血钙浓度分析[J].武警医学,2004,15(9):672-675. 被引量:2
  • 2麦玉洁,李睿,邹德慧,王亚非,赵耀中,杨仁池,王建祥,肖志坚,韩明哲,钱林生,邱录贵.206例多发性骨髓瘤患者不同方案疗效分析[J].中华血液学杂志,2005,26(4):193-196. 被引量:37
  • 3李剑,许莹,李航,沈悌.多发性骨髓瘤合并肾功能不全38例临床和预后分析[J].中国实用内科杂志,2006,26(3):341-343. 被引量:15
  • 4Eleutherakis-Papaiakovou V, Bamias A, Gika D, et al. Renal failure in multiple myeloma: incidence, correlations, and prognostic significance [ J ] . Leuk Lymphoma, 2007, 48 (2) :337-341. 被引量:1
  • 5Blade J, Samson D, Reece D, et al. Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietie stem cell transplantation. Myeloma Subcommittee of the EBMT [ J]. Br J Haematol, 1998, 102(5) :1115-1123. 被引量:1
  • 6Dimopoulos MA, Kastirtis E, Rosinol L, et al. Pathogenesis and treatment of renal failure in multiple myeloma [ J ]. Leukemia, 2008, 22 (8) : 1485-1493. 被引量:1
  • 7Knudsen LM, Hjorth M, Hippe E. Renal failure in multiple myeloma: reversibility and impact on the prognosis. Nordic Myeloma Study Group [ J ]. Eur J Haematol, 2000, 65 (3) : 175-181. 被引量:1
  • 8Samson D, Gaminara E, Newland A, et al. Infusion of vincristine and doxorubicin with oral dexamethasone as first-line therapy for multiple myeloma [ J]. Lancet, 1989, 2 (8668): 882-885. 被引量:1
  • 9Blade J, Fernandez Llama P, Bosch F,et al. Renal fallurein multiple myeloma: presenting features and predictors of out- come in 94 patients from a single institution[J]. Arch Intem Med,1998,158 (17):1889-1893. 被引量:1
  • 10Roussou M, Kastritis E, Miqkou M, et al. Treatment of patients with multiple myeloma complicated by renal failure with bortezomib-based regimens[J]. Leuk Lymphoma, 2008,49 (5):890-895. 被引量:1

共引文献8

同被引文献10

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部